Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...
Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...
PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...
Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd poses a significant risk to Traws Pharma, Inc.’s future ...
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
Zacks Investment Research on MSN
Royalty Pharma (RPRX) earnings expected to grow: Should you buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Royalty Pharma (RPRX) reports results for ...
Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...
News Medical on MSNOpinion
African investment vital for medical research and innovation
Africa’s health future hinges on its ability to finance and commercialise its own medical innovations, rather than rely on ...
My initial rating of Abbott Laboratories is a buy, agreeing with today's Wall Street consensus. The future growth indicators, diversified portfolio across many clinical segments, and leading roles in ...
Lumos Pharma (NASDAQ:LUMO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...
Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical MarketDENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results